In individuals with a hereditary predisposition to breast and ovarian cancer, specifically carriers of the BRCA1/2 PVs/LPVs, early and intensive screening is of paramount importance due to the early age of disease onset. This evidence concerns the gene BRCA1 and ovarian cancer.